Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antiretroviral therapy. Sequencing antiretrovirals.

The AIDS reader - 1 Jun 2000

MacArthur R D

Abstract excerpt

Sequencing of antiretroviral agents is of interest because the majority of HIV-infected individuals in clinical practice experience virologic rebound after 1 to 2 years of therapy. Sequencing strategies are based on the observation that different mutational patterns arise after exposure to particular antiretroviral agents within the same class and on preliminary data suggesting that not all mutations impart the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active
Share to Drug Administration Schedule

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Microbial

Share to Drug Therapy, Combination

Share to HIV Infections

Share to Reverse Transcriptase Inhibitors

Source

Identifiers

PMID: 10881367

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antiretroviral therapy. Sequencing antiretrovirals.PMID 10881367Read ↗

Antiretroviral therapy : optimal sequencing of therapy to avoid resistance.Semantic proximity Read ↗

Sequencing of therapy to avoid resistance and the need for new antiretroviral drugs in the treatment of HIV disease.Semantic proximity Read ↗

Antiretroviral treatment sequencing strategies to overcome HIV type 1 drug resistance in adolescents and adults in low-middle-income countries.Semantic proximity Read ↗

Cross-resistance patterns among HIV protease inhibitors.Semantic proximity Read ↗

Nucleoside and nucleotide analogue reverse transcriptase inhibitors: a clinical review of antiretroviral resistance.Semantic proximity Read ↗

HIV-1 resistance genotyping by sequencing produces inconsistent results for mixed viral populations.Semantic proximity Read ↗

Pharmacogenetics of antiretroviralsSemantic proximity Read ↗

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine.Semantic proximity Read ↗

Treatment. Pre-existing mutation may cause HIV drug resistance.Semantic proximity Read ↗

Extent of cross-resistance between agents used to treat human immunodeficiency virus type 1 infection in clinically derived isolates.Semantic proximity Read ↗

HIV mutagenesis and the evolution of antiretroviral drug resistanceSemantic proximity Read ↗

HIV genotyping by DNA sequencing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.